Angiopoietin-like-4 and minimal change disease

Angiopoietin-Like-4, a Potential Target of Tacrolimus, Predicts Earlier Podocyte Injury in Minimal Change Disease

(2015) Jian-Si Li et al.   PLoS One

The Calcineurin Inhibitor Tacrolimus Reduces Proteinuria in Membranous Nephropathy Accompanied by a Decrease in Angiopoietin-Like-4

(2014) Lei Peng et al.   PLoS One

Dietary modulation of plasma angiopoietin-like protein 4 concentrations in healthy volunteers and in patients with type 2 diabetes

(2013) Jacqueline T Jonker et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome

(2013) Lionel C Clement et al.   NATURE MEDICINE

New Insights Into Human Minimal Change Disease: Lessons From Animal Models

(2011) Sumant S. Chugh et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome

(2010) Lionel C Clement et al.   NATURE MEDICINE

Caloric Restriction and Exercise Increase Plasma ANGPTL4 Levels in Humans via Elevated Free Fatty Acids

(2009) Sander Kersten et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Quantitation of serum angiopoietin-like proteins 3 and 4 in a Finnish population sample

(2009) Marius R. Robciuc et al.   JOURNAL OF LIPID RESEARCH

Suppression of the Raf/MEK/ERK Signaling Cascade and Inhibition of Angiogenesis by the Carboxyl Terminus of Angiopoietin-Like Protein 4

(2008) Ying-Hua Yang et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Interaction of the coiled-coil domain with glycosaminoglycans protects angiopoietin-like 4 from proteolysis and regulates its antiangiogenic activity

(2008) Clémence Chomel et al.   FASEB JOURNAL